PHGE
HEALTHCAREBiomX Inc
$0.64-0.04 (-5.71%)PRE
Live · AMEX · May 9, Close
AI Insight
What's Moving PHGE Today?
No stock-specific AI insight has been generated for PHGE yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.61$13.70
$0.64
Fundamentals
Market Cap$6M
P/E Ratio—
EPS$-37.05
Dividend Yield—
Dividend / Share—
ROE-3.2%
Profit Margin—
Debt / Equity—
Trading
Volume511K
Avg Volume (10D)—
Shares Outstanding8.8M
PHGE News
20 articles- BiomX’s Zorronet Puts Full AI Command-and-Control in the Palm of Your HandYahoo Finance·May 6, 2026
- Zorronet Delivers 98% Success in Israel Railways Pilot, Awarded Framework Supply Agreement for AI-Powered Detection SystemsYahoo Finance·Apr 16, 2026
- BiomX Accelerates Defense Technology Buildout with DFSL AcquisitionYahoo Finance·Apr 13, 2026
- BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security ApplicationsBenzinga·Apr 10, 2026
- BiomX Obtains Option to Acquire Control of Israeli Laser-Radar Counter-Drone SystemBenzinga·Mar 31, 2026
- BiomX Adds Former Mossad Deputy to Advisory BoardYahoo Finance·Mar 30, 2026
- BiomX Inc. Received NYSE American Notification Letter Regarding Stockholders' Equity DeficiencyYahoo Finance·Mar 27, 2026
- BiomX Launches Security Subsidiary in Israel and Will Initially Invest Over $3 million In Its OperationsYahoo Finance·Mar 26, 2026
- Johnson & Johnson Exits 3 Biotechs but Keeps Stakes in These Rumored Acquisition TargetsYahoo Finance·Mar 25, 2026
- BiomX CEO Issues Letter to StockholdersYahoo Finance·Mar 19, 2026
- BiomX Names Michael Oster as Chief Executive Officer, David Rokach Chief Financial Officer to Support Next Phase of GrowthYahoo Finance·Mar 9, 2026
- BiomX Issues Statement Regarding Recent Common Stock Trading ActivityYahoo Finance·Jan 27, 2026
- BiomX announces $3M private placementYahoo Finance·Dec 30, 2025
- All You Need to Know About BiomX (PHGE) Rating Upgrade to BuyYahoo Finance·Dec 29, 2025
- BiomX Announces $3.0 Million Private PlacementYahoo Finance·Dec 29, 2025
- Sector Update: Health Care Stocks Fall Late AfternoonYahoo Finance·Dec 8, 2025
- Top Midday DeclinersYahoo Finance·Dec 8, 2025
- BiomX Announces Discontinuation of Phase 2b BX004 Trial Following Internal ReviewYahoo Finance·Dec 8, 2025
- BiomX Provides Update on BX004 Phase 2b Trial in Cystic FibrosisYahoo Finance·Nov 25, 2025
- BiomX Inc. Announces 1-for-19 Reverse Stock SplitYahoo Finance·Nov 14, 2025
All 20 articles loaded
Price Data
Open$0.69
Previous Close$0.68
Day High$0.71
Day Low$0.64
52 Week High$13.70
52 Week Low$0.61
52-Week Range
$0.61$13.70
$0.64
Fundamentals
Market Cap$6M
P/E Ratio—
EPS$-37.05
Dividend Yield—
Dividend / Share—
ROE-3.2%
Profit Margin—
Debt / Equity—
Trading
Volume511K
Avg Volume (10D)—
Shares Outstanding8.8M
About BiomX Inc
BiomX Inc., a clinical-stage microbiome company, develops products using natural and man-made phage technologies designed to target and kill specific harmful bacteria. The company is headquartered in Ness Ziona, Israel.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeAMEX
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—